2001

30th Hemophilia Symposium Hamburg 1999

ISBN: 978-3-540-67677-5 (Print) 978-3-642-18240-2 (Online)

Table of contents (69 chapters)

previous Page of 4
  1. Front Matter

    Pages I-XXXIV

  2. HIV Infection and Epidemiology in Hemophilia

    1. Front Matter

      Pages 1-1

    2. No Access

      Book Chapter

      Pages 3-10

      Causes of Death and AIDS-Related Disease in Hemophilia Patients in Germany (Inquiries 1999)

  3. Gene Therapy in Hemophilia

    1. Front Matter

      Pages 11-11

    2. No Access

      Book Chapter

      Pages 13-21

      Genotype-Phenotype Correlation in Hemophilia A

  4. Therapy of Hepatitis C

    1. Front Matter

      Pages 23-23

    2. No Access

      Book Chapter

      Pages 25-31

      Current Therapy of Hepatitis C Virus Infection

    3. No Access

      Book Chapter

      Pages 32-34

      Interferon Alpha-2a Treatment in Patients with Hepatitis C and Bleeding Disorders

    4. No Access

      Book Chapter

      Pages 35-41

      Report on Experience in the Treatment of Hepatitis C in HIV-Coinfected Hemophiliacs

  5. Inhibitors in Hemophilia

    1. Front Matter

      Pages 43-43

    2. No Access

      Book Chapter

      Pages 45-52

      A New Therapeutic Option for Inhibitor Elimination in Patients with Acquired Hemophilia

  6. Long-Term Results After Joint Replacement

    1. Front Matter

      Pages 53-53

    2. No Access

      Book Chapter

      Pages 55-61

      Long-Term Results After Total Knee and Total Hip Replacement in Hemophilic Arthropathy

    3. No Access

      Book Chapter

      Pages 62-64

      Total Knee Prosthesis in Hemophiliacs with Multilocular Hemophilic Arthropathy — The Zurich Experience

    4. No Access

      Book Chapter

      Pages 65-70

      Corrective Osteotomy of the Lower Extremity in Hemophilic Arthropathy of the Knee and Hip Joint

  7. Pediatric Hemostasiology

    1. Front Matter

      Pages 71-71

    2. No Access

      Book Chapter

      Pages 73-85

      Anticoagulant Action of Activated Protein C is Diminished by Alpha2-Macroglobulin in Newborn Plasma

    3. No Access

      Book Chapter

      Pages 86-101

      Functional Consequences of Differences in Carbohydrate Sequences of Fetal and Adult Plasminogen and Fibrinogen

    4. No Access

      Book Chapter

      Pages 102-109

      Hereditary Thrombophilic Risk Profiles in Children with Spontaneous Venous Thromboembolism

    5. No Access

      Book Chapter

      Pages 110-113

      Inhibitor Development in Previously Untreated Patients with Hemophilia A and B: A Prospective 23-Year Follow-Up

    6. No Access

      Book Chapter

      Pages 114-116

      HIT Type II without Thrombocytopenia in a 15-Year-Old Boy with Protein S Deficiency and Recurrent Deep Vein Thrombosis

  8. Free Lectures

    1. Front Matter

      Pages 117-117

    2. No Access

      Book Chapter

      Pages 119-125

      Modified Bonn-Malmö Protocol

    3. No Access

      Book Chapter

      Pages 126-131

      A Novel Type of Mutation at the Propeptide Cleavage Site (Ala+1Thr) Causing Symptomatic Protein C Type II Deficiency

    4. No Access

      Book Chapter

      Pages 132-143

      Lithuanian Hemophilia A and B Register Comprising Phenotypic and Genotypic Data

    5. No Access

      Book Chapter

      Pages 144-153

      Greifswald Hemophilia B Study

    6. No Access

      Book Chapter

      Pages 154-160

      Successful Treatment of Patients with von Willebrand Disease Using a High-Purity Double Virus Inactivated FVIII/vWF Concentrate (IMMUNATE)

  9. Research Cooperation

    1. Front Matter

      Pages 161-161

    2. No Access

      Book Chapter

      Pages 163-175

      Industry Sponsoring and Acceptance of Benefit by Hospital Officials: Opportunities and Limits of Third-Party Funding

previous Page of 4